from The American Heritage® Dictionary of the English Language, 4th Edition
- n. Accumulation of fat in the interstitial tissue of an organ.
from Wiktionary, Creative Commons Attribution/Share-Alike License
- n. The abnormal retention of lipids by a cell or organ
from The Century Dictionary and Cyclopedia
- n. Fatty degeneration or infiltration.
- n. Any disease of the sebaceous glands. Also called steatopathia.
Sorry, no etymologies found.
Doctors call the condition steatosis, in which liver cells accumulate lipids.
This non-specific title includes steatosis, non-alcoholic steatohepatitis, fibrosis and cirrhosis.
Percent weight reduction correlated significantly with improvement in NAS and participants who achieved the study weight loss goal (/= 7%), compared with those who lost less than 7%, had significant improvements in steatosis, lobular inflammation, ballooning injury and NAS.
My short list would include sleep apnea, osteoarthritis, hepatic steatosis, polycystic ovary syndrome, infertility, pseudo tumor cerebri and many more.
There were no significant associations between either total caloric intake or protein intake and either steatosis, fibrosis, or inflammation.
There were no significant associations between either total caloric intake or protein intake and either steatosis fatty infiltration, fibrosis, or inflammation.
Accordingly, microscopic examination of the liver revealed the absence of steatosis and inflammation in GFT505-treated mice.
In this context, a series of studies recently performed by GENFIT have demonstrated the efficacy of GFT505 in various pre-clinical models of NAFLD/NASH: In a recognized model of NAFLD/NASH (Methionine-Choline Deficient Diet for 6 weeks in normal or diabetic mice), microscopic examination of the liver showed that GFT505 oral treatment prevented the inflammation and accumulation of fat (steatosis) induced by the diet.
Thus, considering this unmet medical need and its increasing worldwide prevalence, a recent GlobalData analysis stated that any drug with proven efficacy on NAFLD/NASH reduction in liver steatosis, inflammation, and fibrosis which has a favorable safety profile could rapidly become a blockbuster.
The major risk factor for hepatic steatosis is excessive consumption